Abeona Therapeutics Inc. Revenue 2010–2025
Abeona Therapeutics Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Abeona Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 8.7 M, a 2420.23% increase year-over-year.
- Abeona Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 13.6 M, a 85.41% increase year-over-year.
- Abeona Therapeutics Inc. annual revenue for 2025 was 5.8 M, a 66.29% increase from 2023.
- Abeona Therapeutics Inc. annual revenue for 2023 was 3.5 M, a 147.52% increase from 2022.
- Abeona Therapeutics Inc. annual revenue for 2022 was 1.4 M, a 52.87% decrease from 2021.
- Abeona Therapeutics Inc. annual revenue for 2021 was 3.0 M.
Abeona Therapeutics Inc. (ABEO) — Frequently Asked Questions
Abeona Therapeutics Inc. (ABEO) is a publicly traded US company. It has a market capitalization of $354M. In fiscal 2025 it reported revenue of $6M and net income of $71M. Explore ABEO's stock price, financial statements, earnings history, margins and key ratios below.
What is Abeona Therapeutics Inc.'s market cap?
Abeona Therapeutics Inc. (ABEO) has a market capitalization of $354M.
What is the ABEO stock price?
ABEO trades at $5.36 (-1.65% on the day).
How much revenue does Abeona Therapeutics Inc. make?
Abeona Therapeutics Inc. reported revenue of $6M in fiscal 2025.
Is ABEO profitable?
In fiscal 2025, Abeona Therapeutics Inc. reported net income of $71M.